GEC/ESTRO recommendations on high dose rate afterloading brachytherapy for localised prostate cancer: an update.
about
Trends in targeted prostate brachytherapy: from multiparametric MRI to nanomolecular radiosensitizersPerformance and suitability assessment of a real-time 3D electromagnetic needle tracking system for interstitial brachytherapyRecent developments and best practice in brachytherapy treatment planningSingle fraction multimodal image guided focal salvage high-dose-rate brachytherapy for recurrent prostate cancer.Single-fraction high-dose-rate brachytherapy using real-time transrectal ultrasound based planning in combination with external beam radiotherapy for prostate cancer: dosimetrics and early clinical resultsMagnetic resonance image guided brachytherapy.The use of trans-applicator intracavitary ultrasonography in brachytherapy for cervical cancer: phantom study of a novel approach to 3D image-guided brachytherapy.High-dose-rate brachytherapy boost for prostate cancer: rationale and techniqueInterstitial high-dose rate brachytherapy as boost for anal canal cancer.The effectiveness and side effects of conformal external beam radiotherapy combined with high-dose-rate brachytherapy boost compared to conformal external beam radiotherapy alone in patients with prostate cancer.Timing of High-Dose Rate Brachytherapy With External Beam Radiotherapy in Intermediate and High-Risk Localized Prostate CAncer (THEPCA) Patients and Its Effects on Toxicity and Quality of Life: Protocol of a Randomized Feasibility Trial.Dosimetric coverage of the prostate, normal tissue sparing, and acute toxicity with high-dose-rate brachytherapy for large prostate volumesFeasibility and early outcome of high-dose-rate Ir-192 brachytherapy as monotherapy in two fractions within 1 day for high-/very high-risk prostate cancer.Template guided transperineal saturation biopsy of the prostate: lessons for focal and urethra-sparing high-dose-rate brachytherapy for localized prostate cancer.Two-fraction high-dose-rate brachytherapy within a single day combined with external beam radiotherapy for prostate cancer: single institution experience and outcomes.Prostate external beam radiotherapy combined with high-dose-rate brachytherapy: dose-volume parameters from deformably-registered plans correlate with late gastrointestinal complications.High-dose-rate brachytherapy as monotherapy for prostate cancer: technique, rationale and perspective.Hypoxia dose painting in prostate and cervix cancer.High-dose-rate brachytherapy as salvage modality for locally recurrent prostate cancer after definitive radiotherapy : A systematic review.Simultaneous automatic segmentation of multiple needles using 3D ultrasound for high-dose-rate prostate brachytherapy.Salvage prostate re-irradiation using high-dose-rate brachytherapy or focal stereotactic body radiotherapy for local recurrence after definitive radiation therapy.An evaluation of the robustness of organ-at-risk recommendations made by GEC/ESTRO according to interobserver variability: a single-center experience.Prostate cancer boost using high-dose-rate brachytherapy: early toxicity analysis of 3 different fractionation schemes.Predictors of distant metastasis after combined HDR brachytherapy and external beam radiation for prostate cancerHigh-dose rate brachytherapy in localized penile cancer: short-term clinical outcome analysis.Prostate volume and implant configuration during 48 hours of temporary prostate brachytherapy: limited effect of oedema.Outcomes of Asian patients with localized prostate cancer treated with combined intensity modulated radiation therapy (IMRT) and high dose rate (HDR) brachytherapy: A single institution experience.Multisource Rotating Shield Brachytherapy Apparatus for Prostate Cancer.A method to estimate composite doses for organs at risk in prostate cancer patients treated with EBRT in combination with HDR BT.[Focal dose escalation in the treatment of prostate cancer : Long-term results of HDR brachytherapy].Evaluation of tolerance and toxicity of high-dose-rate brachytherapy boost combined with interstitial hyperthermia for prostate cancer.Does microwave interstitial hyperthermia prior to high-dose-rate brachytherapy change prostate volume or therapy plan parameters?High dose-rate brachytherapy in the treatment of prostate cancerMarkers of Prostate Cancer: The Role of Circulating Tumor Markers in the Management of Bone MetastasesPre-implant magnetic resonance and transrectal ultrasound imaging in high-dose-rate prostate brachytherapy: comparison of prostate volumes, craniocaudal extents, and contours
P2860
Q26738622-44944D9B-49E8-43EA-96C2-1AF6D89A2C31Q26775800-03CB19B8-E577-4092-8BE8-6FFF54D7B227Q27027841-1972B5B8-2519-4407-9CFA-7E1357086B28Q30376901-F44200DC-3CEF-4EDF-AE8A-C7588293BFD2Q30382135-373621CF-3844-4D3E-B01F-D78544FD84ACQ30586499-4291D765-F29F-4452-A783-4B24F419EEE4Q33704921-5BBD3305-CAF1-4AEC-91FD-7D6C5E9F75BDQ34355194-AACB7013-F82F-45F0-BF7F-5DEC0B4EC6BCQ34499551-B545C3BC-975F-4BEB-A6A7-1AC2535C8FA6Q35166901-B836BF02-F4D1-48E9-A896-EF3114D8564CQ35603519-3EE2E3B8-6F38-43BC-AB44-2F6418DDFFC8Q36575937-57BAD566-9939-4850-9091-80141EF70E8BQ36824994-4FE50AA2-5D43-41B1-BFC2-642F7900B2E6Q36918476-B6BD8C33-1704-4074-8438-3D62D38A98E5Q37025528-E84C0FD4-EDDD-4355-B835-E6F269976EBDQ37380104-941741B5-CE3B-4E9A-B966-9A73FADA32A8Q37730056-02936937-CA05-416B-9895-E27F087E151CQ38413800-75FE648E-35FB-4FD8-B93A-EBC72D76EFF1Q38721676-C5CED0DA-0110-4BEF-A7A7-CD44F1B129B0Q38761653-4B8B545D-E527-4AC7-8EF2-52051E7AE958Q40301889-71FE5729-7757-41F0-B725-29940132E71BQ41061949-3A422607-24EB-4F79-9D89-402D6FF8F213Q41886788-156E780D-7E5D-461B-B572-83D3A14C79BBQ42677918-9FA1F580-EA92-4B04-A34A-4601D183445FQ42722128-6A09BFEC-DE56-4F6A-B534-BC4CE500BD0EQ43041303-32C9119C-916A-43DF-84C1-64ADDA0B35F6Q47420362-7920E372-2496-4DA6-9BCD-59D4FA685226Q47751134-992292AC-FABD-4E4E-A3A4-D9C8BC57F709Q48893261-F37900D0-B7FB-4836-B529-63E36DE9DCB3Q53067194-6AEFE4A1-8837-4CC8-BD3D-C9F834648044Q53127875-874EC977-B521-486A-8A43-4C27595DC4BAQ53540332-D7D88212-2776-42E3-8ED6-970667DC0767Q57112470-3D2A4149-23BC-4FA8-A3D3-FFCC486DE2F0Q58487854-B7601C54-B1CE-4558-B292-3499BE42AD37Q58779714-9CFCFA63-BED3-4688-8FF9-C7F7D332791A
P2860
GEC/ESTRO recommendations on high dose rate afterloading brachytherapy for localised prostate cancer: an update.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
GEC/ESTRO recommendations on h ...... ed prostate cancer: an update.
@en
type
label
GEC/ESTRO recommendations on h ...... ed prostate cancer: an update.
@en
prefLabel
GEC/ESTRO recommendations on h ...... ed prostate cancer: an update.
@en
P2093
P1476
GEC/ESTRO recommendations on h ...... ed prostate cancer: an update.
@en
P2093
Alessandro Colombo
Frank-Andre Siebert
Gyorgy Kovacs
Peter J Hoskin
Peter Niehoff
Taran Paulsen Hellebust
P304
P356
10.1016/J.RADONC.2013.05.002
P50
P577
2013-06-14T00:00:00Z